These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Panic disorder: clinical features, neurobiology, and pharmacotherapy. Breier A N Y State J Med; 1991 Nov; 91(11 Suppl):43S-47S. PubMed ID: 1771059 [TBL] [Abstract][Full Text] [Related]
47. Interactive model of therapeutic response in panic disorder: moclobemide, a case in point. Uhlenhuth EH; Warner TD; Matuzas W J Clin Psychopharmacol; 2002 Jun; 22(3):275-84. PubMed ID: 12006898 [TBL] [Abstract][Full Text] [Related]
56. Does concurrent drug intake affect the long-term outcome of group cognitive behaviour therapy in panic disorder with or without agoraphobia? Oei TP; Llamas M; Evans L Behav Res Ther; 1997 Sep; 35(9):851-7. PubMed ID: 9299805 [TBL] [Abstract][Full Text] [Related]
57. Panic disorder. When symptoms have no apparent physical cause. Katerndahl DA Postgrad Med; 1997 Jan; 101(1):147-50, 153-4, 159-60 passim. PubMed ID: 9008694 [TBL] [Abstract][Full Text] [Related]
58. [Clinical, pathogenetic and therapeutic aspects of panic disorder in patients with chronic alcoholism (review)]. Tsygankov DB; Agasarian EG; Terekhova DA Zh Nevrol Psikhiatr Im S S Korsakova; 2007; Suppl 1():63-70. PubMed ID: 18924468 [TBL] [Abstract][Full Text] [Related]
59. [Indications for antidepressive medication]. Soini M Duodecim; 1997; 113(3):255. PubMed ID: 11370036 [No Abstract] [Full Text] [Related]